"The future of molecular targeted therapy requires a detailed understanding of translational R&D and economics."
Fri 24 May 2013
Don't miss our
Brussels, 4-5 Oct. 2012
Preclinical/early clinical biomarker discovery
Vienna, 29 -30 Nov 2012
Present and future breast cancer management: bench to bedside and back